Ardelyx (ARDX) EBIT Margin Growth (3y) (2018 - 2026)
Ardelyx (ARDX) EBIT Margin Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,942.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn | 19,454.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19,454.00 |
| Dec 31, 2025 | -2,341.00 |
| Sep 30, 2025 | 57,612.00 |
| Jun 30, 2025 | 102,307.00 |
| Mar 31, 2025 | 589,262.00 |
| Dec 31, 2024 | 343,489.00 |
| Sep 30, 2024 | 360,295.00 |
| Jun 30, 2024 | 339,586.00 |
| Mar 31, 2024 | 43,263.00 |
| Dec 31, 2023 | 144,664.00 |
| Sep 30, 2023 | 64,567.00 |
| Jun 30, 2023 | 124,403.00 |
| Mar 31, 2023 | 156,539.00 |
| Dec 31, 2022 | 86,518.00 |
| Sep 30, 2022 | 29,429.00 |
| Jun 30, 2022 | 13.69 Mn |
| Dec 31, 2021 | 2.88 Mn |
| Sep 30, 2021 | 1.02 Mn |
| Jun 30, 2021 | 7.04 Mn |
| Mar 31, 2021 | 27,603.00 |